Mizuho Markets Americas’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,200
Closed -$3.86M 253
2026
Q1
$3.86M Sell
4,200
-9,800
-70% -$9.94M 0.11% 104
2025
Q4
$15M Hold
14,000
0.29% 82
2025
Q3
$10.7M Buy
+14,000
New +$10.4M 0.2% 74
2025
Q1
Sell
-100,000
Closed -$77.2M 246
2024
Q4
$77.2M Buy
+100,000
New +$82.8M 1.38% 19
2023
Q1
Sell
-59,200
Closed -$21.7M 95
2022
Q4
$21.7M Buy
+59,200
New +$21M 1.28% 19

Other funds holding LLY

Mizuho Markets Americas's LLY Position: Q2 2026 in Review

Mizuho Markets Americas sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 4,200 shares — an estimated $3.86M sold.

Mizuho Markets Americas first reported a position in LLY in Q4 2022 and held it in 5 quarters. The position peaked at $77.2M in Q4 2024. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mizuho Markets Americas reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Mizuho Markets Americas sold 4,200 Eli Lilly shares in Q2 2026, an estimated $3.86M.
  • Mizuho Markets Americas first reported a position in Eli Lilly in Q4 2022 and held it in 5 quarters.
  • Mizuho Markets Americas's Eli Lilly position peaked at $77.2M in Q4 2024.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mizuho Markets Americas's 13F filing for Q2 2026, filed 24 Jul 2026.